During the past decade, Atlanta Cancer Care conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Cancer Care" #1 sponsor was "Celgene" with 2 trials, followed by "Celldex Therapeutics" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Oncotherapeutics" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Cancer Care" #1 collaborator was "PRA Health Sciences" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Cancer Care" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Giant Cell Glioblastoma" (2 trials), "Glioblastoma" (2 trials) and "Glioblastoma With Oligodendroglial Component" (2 trials). Many other conditions were trialed in "Atlanta Cancer Care" in a lesser frequency.

Most popular intervention types in "Atlanta Cancer Care" are "Drug" (18 trials), "Procedure" (2 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Gemcitabine" (2 trials), "KLH" (2 trials), "Rindopepimut (CDX-110) with GM-CSF" (2 trials) and "ascorbic acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Cancer Care" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Atlanta Cancer Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Atlanta Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Cancer Care, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Atlanta Cancer Care has several departments that took part in Clinical trials: "Atlanta Cancer Care" - 2 trials, "Atlanta Cancer Care - Cumming" - 3 trials, "Atlanta Cancer Care - Conyers" - 2 trials, "Atlanta Cancer Care - Stockbridge" - 2 trials